News for Indivior PLC (2IV.MU)

Geneva, Switzerland, February 17, 2021 -- https://www.globenewswire.com/Tracker?data=x7m9iGcmcrO8Ea211FsG1YHOEG0nqizO3vBGnCIH6eSX9fdeMZA80zGeiCebm4jj1oQY8BTr08sTjFFwIF6oD2Ja0mUnaWpimZy_Sheccgk=... | February 17, 2021

First patient treated with ADX71149 scheduled for Q2 2021 Geneva, Switzerland, January 21, 2021 --... | January 21, 2021

First patient treated with ADX71149 (JNJ-40411813) scheduled for Q2 2021Geneva, Switzerland, January 21, 2021 – Addex Therapeutics (SIX: ADX...

Pune, India, Jan. 13, 2021 (GLOBE NEWSWIRE) -- The global opioid use disorder market is expected to experience exponential growth by reaching USD 4.87 ...

Key Prominent Players Covered in the Opioid Use Disorder Market Research Report Are Indivior PLC, Alkermes, Orexo AB, Titan Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Mallinckrodt, Pharmaceuticals, BioDelivery Sciences International Inc., Viatris Inc., Pfizer, Inc., Hikma Pharmaceuticals PLC, Camurus Ltd. and other key market players.

Geneva, Switzerland, January 11, 2021 -- Addex Therapeutics... | January 11, 2021